Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
John B. Sunwoo(Palo Alto University), Carter Van Waes(National Institute on Deafness and Other Communication Disorders), C C Bancroft(National Institutes of Health), Zhong Chen(Sun Yat-sen University), Julian Adams, Peter J. Elliott(Advanced Process Combinatorics (United States)), Ning T. Yeh, Edward A. Sausville(University of Maryland, Baltimore), Guo‐Chung Dong
PubMed
May 1, 2001
Cited by 479
Related Papers
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
|Cancer Cell|2017|656
Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes
|Nature Genetics|2015|400
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
|Cell Metabolism|2018|332
STAT3: A critical transcription activator in angiogenesis
|Medicinal Research Reviews|2007|312